首页> Research and practice in thrombosis and haemostasis> The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B.

The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B.

导出 LinkOut

翻译打印收藏纠错

第一作者： Haowei Linda,Sun

第一单位： Division of Hematology Department of Medicine University of Alberta Edmonton Alberta Canada.

作者： Haowei Linda,Sun ^[1] ; Ming,Yang ^[2] ; Man-Chiu,Poon ^[3] ; Adrienne,Lee ^[3] ; K Sue,Robinson ^[4] ; Michelle,Sholzberg ^[5] ; John,Wu ^[6] ; Alfonso,Iorio ^[7] ; Victor,Blanchette ^[8] ; Manuel,Carcao ^[8] ; Robert J,Klaassen ^[9] ; Shannon,Jackson ^[10]

作者单位： Division of Hematology Department of Medicine University of Alberta Edmonton Alberta Canada. ^[1] British Columbia Hemophilia Treatment Centre - Adult Division Vancouver British Columbia Canada. ^[2] Department of Medicine Foothills Medical Centre Cumming School of Medicine University of Calgary Calgary Alberta Canada. ^[3] Division of Hematology Department of Medicine University of Dalhousie Halifax Nova Scotia Canada. ^[4] Division of Hematology Departments of Medicine and Laboratory Medicine & Pathobiology St. Michael's Hospital Toronto Ontario Canada. ^[5] Division of Hematology Oncology British Columbia Children and Women's Hospital Vancouver British Columbia Canada. ^[6] Division of Hematology Department of Medicine McMaster University Hamilton Ontario Canada. ^[7] Division of Hematology/Oncology Department of Pediatrics The Hospital for Sick Children University of Toronto Toronto Ontario Canada. ^[8] Division of Hematology Oncology Department of Pediatrics Children's Hospital of Eastern Ontario Research Institute Ottawa Ontario Canada. ^[9] British Columbia Hemophilia Treatment Centre - Adult Division Vancouver British Columbia Canada.;Division of Hematology Department of Medicine University of British Columbia Vancouver British Columbia Canada. ^[10]

关键词 extended half‐life hemophilia A hemophilia B patient‐reported outcomes quality of life

DOI 10.1002/rth2.12601

PMID 34667922

发布时间 2023-09-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Research and practice in thrombosis and haemostasis

2021年5卷7期

e12601页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Research and practice in thrombosis and haemostasis

2021年5卷7期

e12601页

检索历史清除

The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B.

Research and practice in thrombosis and haemostasis

相似文献

同项目论文

Research and practice in thrombosis and haemostasis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B.

Research and practice in thrombosis and haemostasis

相似文献

同项目论文

Research and practice in thrombosis and haemostasis

相关期刊

检索历史清除